Where did it all go wrong? Scientists identify 'cell of origin' in skin cancers

July 8, 2016, University of Cambridge
The green-labelled cells show a basal cell carcinoma in mouse tail epidermis derived from a single mutant stem cell and expanding out of the normal epidermis stained in red. Credit: Adriana Sánchez-Danés

Scientists have identified for the first time the 'cell of origin' - in other words, the first cell from which the cancer grows - in basal cell carcinoma, the most common form of skin cancer, and followed the chain of events that lead to the growth of these invasive tumours.

Our is kept healthy by a constant turnover, with dying skin being shed and replaced by new cells. The process is maintained by 'progenitor' cells - the progeny of - that divide and 'differentiate' into fully-functional skin cells to replenish dying skin. These cells are in turn supported by a smaller population of 'stem cells', which remain silent, ready to become active and repair skin when it becomes damaged.

However, when this process goes awry, cancers can arise: damaged DNA or the activation of particular genes known as 'oncogenes' can trigger a cascade of activity that can lead ultimately to unchecked proliferation, the hallmark of a cancer. In some cases, these tumours may be benign, but in others, they can spread throughout the body - or 'metastasise' - where they can cause organ failure.

Until now, there has been intense interest in the scientific field about which types of cell - stem cell, progenitor cell or both - can give rise to tumours, and how those cells become transformed in the process of tumour initiation and growth. Now, in a study published in Nature, researchers led by Professor Cédric Blanpain at the Université Libre de Bruxelles, Belgium, and Professor Ben Simons at the University of Cambridge, have demonstrated in mice how skin stem and progenitor cells respond to the activation of an oncogene. Their studies have shown that, while progenitor cells can give rise to , only stem cells have the capacity to develop into deadly invasive tumours.

The researchers used a transgenic mouse model - a mouse whose genes had been altered to allow the activation of an oncogene in individual stem and progenitor cells. The oncogene was coupled with a fluorescent marker so that cells in which the oncogene was active could be easily identified, and as these cells proliferate, their 'daughter' cells could also be tracked. These related, fluorescent cells are known as 'clones'.

By analysing the number of fluorescently-labelled cells per clone using mathematical modelling, the team was able to show that only clones derived from mutant stem cells were able to overcome a mechanism known as 'apoptosis', or programmed cell death, and continue to divide and proliferate unchecked, developing into a form of known as . In contrast, the growth of clones derived from becomes checked by increasing levels of apoptosis, leading to the formation of benign lesions.

"It's incredibly rare to identify a cancer cell of origin and until now no one has been able to track what happens on an individual level to these cells as they mutate and proliferate," says Professor Blanpain. "We now know that stem cells are the culprits: when an oncogene in a stem cell becomes active, it triggers a chain reaction of cell division and proliferation that overcomes the cell's safety mechanisms."

"While this has solved a long-standing scientific argument about which cell types can lead to invasive skin tumours, it is far more than just a piece of esoteric knowledge," adds Professor Simons. "It suggests to us that targeting the pathways used in regulating - how stem cells choose between cell proliferation and differentiation - could be a more effective way of halting tumours in their tracks and lead to potential new therapies."

Explore further: Skin regeneration is product of two types of stem cells

More information: Sánchez-Danés, A et al. Defining the clonal dynamics leading to mouse skin tumour initiation. Nature; 8 July 2016, DOI: 10.1038/nature19069

Related Stories

Skin regeneration is product of two types of stem cells

May 20, 2016
Stem cells are essential for tissue regeneration and, in a recent study, Cornell researchers have challenged a long-standing model regarding epidermal stem cells and their role in skin repair.

New mechanism that regulates tumour initiation and invasion in skin basal cell carcinoma

June 24, 2015
Researchers at the Université libre de Bruxelles, ULB uncover a new mechanism that regulates tumour initiation and invasion in skin basal cell carcinoma.

Common chemical highly toxic to blood cell precursors

June 24, 2016
Malaysian scientists have provided evidence that a widely used chemical is more toxic to certain blood cell precursors in the bone marrow than to others.

Recommended for you

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

New method uses just a drop of blood to monitor lung cancer treatment

October 17, 2018
Dr. Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. This discovery led to a set of anti-cancer medications called checkpoint inhibitors, one of the first of ...

Researcher fighting breast cancer with light therapy

October 17, 2018
When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.

Gene screening technique helps identify genes involved in a fatty liver-associated liver cancer

October 17, 2018
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack. This has certainly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.